Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management

2017 ◽  
Vol 120 ◽  
pp. 219-225 ◽  
Author(s):  
T.P. Johnston ◽  
T.A. Korolenko ◽  
M. Pirro ◽  
A. Sahebkar
Keyword(s):  
Heart Disease ◽  
Cardiovascular Heart Disease ◽  
Cholesterol Management

Determination of Dietary Status as a Risk Factor of Cardiovascular Heart Disease in Turkish Elderly People

2015 ◽  
Vol 54 (4) ◽  
pp. 328-341 ◽  
Author(s):  
Alev Keser ◽  
Nurcan Yabanci Ayhan ◽  
Pelin Bilgiç ◽  
Muhittin Tayfur ◽  
Işil ŞImşek
Keyword(s):  
Risk Factor ◽  
Heart Disease ◽  
Elderly People ◽  
Cardiovascular Heart Disease

TAB2 variants cause cardiovascular heart disease, connective tissue disorder and developmental delay

2021 ◽  
Author(s):  
Jennifer Hanson ◽  
Daniel Brezavar ◽  
Susan Hughes ◽  
Shivarajan Amudhavalli ◽  
Emily Fleming ◽  
...  
Keyword(s):  
Heart Disease ◽  
Connective Tissue ◽  
Developmental Delay ◽  
Connective Tissue Disorder ◽  
Cardiovascular Heart Disease

scholarly journals Making Informed CHOICES: The Launch of a “Big Data” Pragmatic Trial to Improve Cholesterol Management and Prevent Heart Disease in Ontario

2020 ◽  
Vol 22 (4) ◽  
pp. 6-9
Author(s):  
Laura Ferreira-Legere ◽  
Anna Chu ◽  
Mohammed Rashid ◽  
Atul Sivaswamy ◽  
Tara O'Neill ◽  
...  
Keyword(s):  
Big Data ◽  
Heart Disease ◽  
Pragmatic Trial ◽  
Cholesterol Management

Relation of lipoprotein(a) in 11- to 19-year-old adolescents to parental cardiovascular heart disease

1993 ◽  
Vol 39 (3) ◽  
pp. 477-480 ◽  
Author(s):  
J C Vella ◽  
E Jover
Keyword(s):  
Heart Disease ◽  
Ldl Cholesterol ◽  
Low Density Lipoprotein ◽  
Density Lipoprotein ◽  
Hdl Cholesterol ◽  
Young Population ◽  
Serum Samples ◽  
Apo B ◽  
Lipoprotein A ◽  
Cardiovascular Heart Disease

Abstract We studied several risk factors in relation to parental cardiovascular heart disease: total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, apolipoprotein (apo) A-I, apo B, and lipoprotein(a) [Lp(a)] were determined in 322 serum samples (43 from subjects with and 279 without parental cardiovascular heart disease). The distribution of Lp(a) concentrations in our young population was similar to that of other white populations, i.e., markedly skewed, with higher frequencies at low values. As compared with children whose parents did not report cardiovascular heart disease, those with affected parents had a higher mean Lp(a) (0.23 vs 0.18 g/L; P < 0.05). Moreover, 42% of the children with parental cardiovascular heart disease, but only 19% of those with no parental cardiovascular heart disease, exhibited Lp(a) values > 0.30 g/L. These results suggest not only that Lp(a) is an important risk factor for cardiovascular heart disease, but also that Lp(a) is more strongly related to the risk of cardiovascular heart disease than are HDL- and LDL-cholesterol and apo A-I and B.

PP-070 [AJC » Preventive cardiology] Healty Lifestyle Behaviours of the Cardiovascular Heart Disease Patients

2017 ◽  
Vol 119 (8) ◽  
pp. e73
Author(s):  
Özlem Persil Özkan ◽  
Serkan Kemal Büyükünal ◽  
Yusuf İnci ◽  
Zerrin Yiğit ◽  
Şule Şakar
Keyword(s):  
Heart Disease ◽  
Preventive Cardiology ◽  
Lifestyle Behaviours ◽  
Cardiovascular Heart Disease

Paraoxonase and risk of cardiovascular heart disease

2001 ◽  
Vol 2 (2) ◽  
pp. 69
Author(s):  
C. Garcés ◽  
M. Benavente ◽  
R. Rubio ◽  
E. Viturro ◽  
C. Maicas ◽  
...  
Keyword(s):  
Heart Disease ◽  
Cardiovascular Heart Disease
Sign in / Sign up

Export Citation Format

Share Document